Clinical Trial

A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)

Name: A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010) — clinical trial record (NCT07266818)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.

Protocol Amendment History 3 changes

critical Trial completed 2026-04-29

notable Primary completion pushed: 2026-03-11 -> 2026-04-13 2026-04-14

minor Completion pushed: 2026-03-11 -> 2026-04-13 2026-04-14

Trial Details

NCT Number	NCT07266818
Lead Sponsor	Merck Sharp & Dohme LLC
Conditions	Healthy
Enrollment	30 participants
Start Date	2025-12-18
Primary Completion	2026-04-09 (estimated)
Study Completion	2026-04-09 (estimated)
Updated on ClinicalTrials.gov	2026-04-28